Association of HLA-DRB1* and keloid disease in an Afro-Caribbean population

Clinical and Experimental Dermatology

Volumn 35, Issue 3, 2010, Pages 305-310

  Brown, J J ^a,b   Ollier, W E R ^a   Arscott, G ^c   Bayat, A ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF THE WEST INDIES   (Jamaica)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNICITY; FEMALE; HUMAN; JAMAICA; KELOID; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; OLIGONUCLEOTIDE PROBE; PATHOGENESIS; PHENOTYPE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HLA-DR ANTIGENS; HUMANS; JAMAICA; KELOID; MALE; MIDDLE AGED; PHENOTYPE; POLYMERASE CHAIN REACTION; WOUND HEALING; YOUNG ADULT;

EID: 77749344484     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2009.03506.x     Document Type: Article

References (25)

1. Bayat A, McGrouther DA. Clinical management of skin scarring. Skinmed 2005 4 : 165 173.
2. Bayat A, Arscott G, Ollier WE et al. Keloid disease: clinical relevance of single versus multiple site scars. Br J Plast Surg 2005 58 : 28 37.
3. Seifert O, Bayat A, Geffers R et al. Identification of unique gene expression patterns within different lesional sites of keloids. Wound Repair Regen 2008 16 : 254 265.
4. Omo-Dare P. Genetic studies on keloid. J Natl Med Assoc 1975 67 : 428 432.
5. Marneros AG, Norris JE, Olsen BR, Reichenberger E. Clinical genetics of familial keloids. Arch Dermatol 2001 137 : 1429 1434.
6. Tiwari JL, Terasaki PI. HLA-DR and disease associations. Prog Clin Biol Res 1981 58 : 151 163.
7. Santucci M, Borgognoni L, Reali UM, Gabbiani G. Keloids and hypertrophic scars of Caucasians show distinctive morphologic and immunophenotypic profiles. Virchows Arch 2001 438 : 457 463.
8. Chen D, Bao W, Wang Q. Immunological regulations of dendritic cell in abnormal scarring tissue. Zhonghua Zheng Xing Wai Ke Za Zhi 2001 17 : 282 284.
9. Chen D, Wang Q, Bao W et al. Role of HLA-DR and CD1a molecules in pathogenesis of hypertrophic scarring and keloids. Chin Med J (Engl) 2003 116 : 314 315.
10. Castagnoli C, Stella M, Magliacani G et al. Similar ectopic expression of ICAM-1 and HLA class II molecules in hypertrophic scars following thermal injury. Burns 1994 20 : 430 433.
11. Castagnoli C, Trombotto C, Ondei S et al. Characterization of T-cell subsets infiltrating post-burn hypertrophic scar tissues. Burns 1997 23 : 565 572.
12. Brown JJ, Ollier WE, Thomson W, Bayat A. Positive association of HLA-DRB1*15 with keloid disease in Caucasians. Int J Immunogenet 2008 35 : 303 307.
13. Joung CI, Jun JB, Chung WT et al. Association between the HLA-DRB1 gene and clinical features of systemic sclerosis in Korea. Scand J Rheumatol 2006 35 : 39 43.
14. Jagadeesan J, Bayat A. Transforming growth factor beta (TGFbeta) and keloid disease. Int J Surg 2007 5 : 278 285.
15. Bayat A, Bock O, Mrowietz U et al. Genetic susceptibility to keloid disease and hypertrophic scarring: transforming growth factor beta1 common polymorphisms and plasma levels. Plast Reconstr Surg 2003 111 : 535 543.
16. Bayat A, Bock O, Mrowietz U et al. Genetic susceptibility to keloid disease and transforming growth factor beta 2 polymorphisms. Br J Plast Surg 2002 55 : 283 286.
17. Bayat A, Walter JM, Bock O et al. Genetic susceptibility to keloid disease: mutation screening of the TGFbeta3 gene. Br J Plast Surg 2005 58 : 914 921.
18. Bayat A, Bock O, Mrowietz U et al. Genetic susceptibility to keloid disease: transforming growth factor beta receptor gene polymorphisms are not associated with keloid disease. Exp Dermatol 2004 13 : 120 124.
19. Brown JJ, Ollier W, Arscott G et al. Genetic susceptibility to keloid scarring: SMAD gene SNP frequencies in Afro-Caribbeans. Exp Dermatol 2008 17 : 610 613.
20. Marneros AG, Norris JE, Watanabe S et al. Genome scans provide evidence for keloid susceptibility loci on chromosomes 2q23 and 7p11. J Invest Dermatol 2004 122 : 1126 1132.
21. Montserrat V, Galocha B, Marcilla M et al. HLA-B*2704, an allotype associated with ankylosing spondylitis, is critically dependent on a transporter associated with antigen processing and relatively independent of tapasin and immunoproteasome for maturation, surface expression, and T cell recognition: relationship to B*2705 and B*2706. J Immunol 2006 177 : 7015 7023.
22. Hirose S, Jiang Y, Nishimura H, Shirai T. Significance of MHC class II haplotypes and IgG Fc receptors in SLE. Springer Semin Immunopathol 2006 28 : 163 174.
23. Annese V, Piepoli A, Latiano A et al. HLA-DRB1 alleles may influence disease phenotype in patients with inflammatory bowel disease: a critical reappraisal with review of the literature. Dis Colon Rectum 2005 48 : 57 64.
24. Rybicki BA, Walewski JL, Maliarik MJ et al. The BTNL2 gene and sarcoidosis susceptibility in African Americans and Whites. Am J Hum Genet 2005 77 : 491 499.
25. Stenzel A, Lu T, Koch WA et al. Patterns of linkage disequilibrium in the MHC region on human chromosome 6p. Hum Genet 2004 114 : 377 385.